Tuygun 2012.

Methods	Retrospective cohort study
Participants	50 confirmed cases
Interventions	Oral ribavirin 30 mg/kg as an initial loading dose, then 15 mg/kg every 6 h for 4 days, and then 7.5 mg/kg every 8 h for 6 days
Outcomes	Mortality
Location and dates	Dr Sami Ulus Maternity and Children’s Health and Diseases Training and Research Hospital in Ankara, Turkey; tertiary centre 2005 ‐ 2010
Number of days since onset of symptoms (mean/SD)	3.5 ± 2.1 (range = 1.0 to 9.0)
Supportive therapy	Erythrocyte/thrombocyte suspension, FFP based on homeostatic status and other supportive care
Notes

Abbreviations: FFP = fresh frozen plasma; h = hours; NR: not reported; PRC: packed red cells; RBV: ribavirin; SAE: serious adverse event; SD: standard deviation